Emergence of
Morganellaceae
Harboring
bla
IMP-27
Metalloenzyme in Canada

David A. Boyd; Laura F. Mataseje; Tanis Dingle; Linda Hoang; Brigitte Lefebvre; Allison McGeer; Roberto G. Melano; Ian Stuart; Andrew Walkty; Amanda Wilmer; Michael R. Mulvey

doi:10.1128/mSphere.00048-21

mSphere (Jun 2021)

Emergence of Morganellaceae Harboring bla IMP-27 Metalloenzyme in Canada

David A. Boyd,
Laura F. Mataseje,
Tanis Dingle,
Linda Hoang,
Brigitte Lefebvre,
Allison McGeer,
Roberto G. Melano,
Ian Stuart,
Andrew Walkty,
Amanda Wilmer,
Michael R. Mulvey

Affiliations

David A. Boyd: ORCiD; Antimicrobial Resistance & Nosocomial Infections, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
Laura F. Mataseje: Antimicrobial Resistance & Nosocomial Infections, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
Tanis Dingle: University of Alberta, Provincial Laboratory for Public Health, Edmonton, Alberta, Canada
Linda Hoang: Bacteriology & Mycology, BCCDC Public Health Laboratory, Vancouver, British Columbia, Canada
Brigitte Lefebvre: Laboratoire de Santé Publique du Québec, Institut National de Santé Publique du Québec, Sainte-Anne-de-Bellevue, Québec, Canada
Allison McGeer: Department of Microbiology, Mount Sinai Hospital, Toronto, Ontario, Canada
Roberto G. Melano: ORCiD; Public Health Ontario Laboratories, Toronto, Ontario, Canada
Ian Stuart: Horizon Health Network, Fredricton, New Brunswick, Canada
Andrew Walkty: ORCiD; Departments of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
Amanda Wilmer: Department of Laboratory Medicine, Kelowna General Hospital, Kelowna, British Columbia, Canada
Michael R. Mulvey: Antimicrobial Resistance & Nosocomial Infections, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada

DOI: https://doi.org/10.1128/mSphere.00048-21
Journal volume & issue: Vol. 6, no. 3

Abstract

Read online

Over the last decade or so, the frequency of isolation of clinical carbapenemase-producing organisms (CPOs) has increased among health care-associated infections. This may seriously compromise antimicrobial therapy, as carbapenems are considered the last line of defense against these organisms.

Published in mSphere

ISSN: 2379-5042 (Online)
Publisher: American Society for Microbiology
Country of publisher: United States
LCC subjects: Science: Microbiology
Website: https://journals.asm.org/journal/msphere

About the journal